Evidence map›Paper›PMID 35921439›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2022

Targeting acetyl-CoA metabolism attenuates the formation of fear memories through reduced activity-dependent histone acetylation.

Desi C Alexander, Tanya Corman, Mariel Mendoza, Andrew Glass, Tal Belity, Ranran Wu, Rianne R Campbell, Joseph Han, Ashley A Keiser, Jeffrey Winkler and 7 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Mitochondrial CaNature metabolism · 2026
    Article
  7. ACSS2 upregulation enhances neuronal resilience to aging and tau-associated neurodegeneration.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Basic Epigenetic Mechanisms.Sub-cellular biochemistry · 2025
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 2 countries.

Desi C AlexanderEpigenetics Institute, University of Pennsylvania, Philadelphia, PA 19104.
Tanya CormanEpigenetics Institute, University of Pennsylvania, Philadelphia, PA 19104.
Mariel MendozaEpigenetics Institute, University of Pennsylvania, Philadelphia, PA 19104.
Andrew GlassDepartment of Chemistry, University of Pennsylvania, Philadelphia, PA 19104.
Tal BelityDepartment of Clinical Biochemistry and Pharmacology, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer-Sheva, 8410501, Israel.
Ranran WuEpigenetics Institute, University of Pennsylvania, Philadelphia, PA 19104.
Rianne R CampbellDepartment of Neurobiology and Behavior, Center for the Neurobiology of Learning and Memory, University of California, Irvine, CA 92697.
Joseph HanDepartment of Neurobiology and Behavior, Center for the Neurobiology of Learning and Memory, University of California, Irvine, CA 92697.
Ashley A KeiserDepartment of Neurobiology and Behavior, Center for the Neurobiology of Learning and Memory, University of California, Irvine, CA 92697.
Jeffrey WinklerDepartment of Chemistry, University of Pennsylvania, Philadelphia, PA 19104.
Marcelo A WoodDepartment of Neurobiology and Behavior, Center for the Neurobiology of Learning and Memory, University of California, Irvine, CA 92697.
Thomas KimEpivario, Inc., Philadelphia, PA 19104.
Benjamin A GarciaEpigenetics Institute, University of Pennsylvania, Philadelphia, PA 19104.
Hagit CohenDepartment of Clinical Biochemistry and Pharmacology, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer-Sheva, 8410501, Israel.
Philipp MewsFishberg Department of Neuroscience and Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029.
Gabor EgervariEpigenetics Institute, University of Pennsylvania, Philadelphia, PA 19104.
Shelley L BergerEpigenetics Institute, University of Pennsylvania, Philadelphia, PA 19104.ORCID 0000-0001-5398-4400
University of Pennsylvania · USUniversity of California, Irvine · USBen-Gurion University of the Negev · ILAllen Institute for Brain Science · US

Funding

Shared Resources Core 2: Quantitative Proteomics CoreP01CA196539 · NCI · ROCKEFELLER UNIVERSITY · PI MUIR, TOM · 2015 to 2024
$17.6M
TRAINING PROGRAM IN CELL AND MOLECULAR BIOLOGYT32GM007229 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI BARTOLOMEI, MARISA S. · 1985 to 2023
$14.0M
The Intellectual and Developmental Disabilities Research Center at CHOP/PennU54HD086984 · NICHD · CHILDREN'S HOSP OF PHILADELPHIA · PI SCHULTZ, ROBERT THOMAS · 2016 to 2020
$6.3M
Viral modulation of epitranscriptomic mechanismsR01AI118891 · NIAID · WASHINGTON UNIVERSITY · PI GARCIA, BENJAMIN A, WEITZMAN, MATTHEW D. · 2015 to 2025
$5.4M
The metabolic-epigenetic axis in memoryR01AA027202 · NIAAA · UNIVERSITY OF PENNSYLVANIA · PI BERGER, SHELLEY L · 2019 to 2023
$2.2M
Defining the metabolic-epigenetic regulation of neuronal chromatin by alcoholK99AA027839 · NIAAA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MEWS, PHILIPP · 2020 to 2021
$309k
Developing a novel epigenetic regulator as a treatment for cocaine use disorderR43DA060726 · NIDA · EPIVARIO, LLC · PI KIM, THOMAS · 2024 to 2024
$295k
Epigenetic-metabolic aspects of alcohol use disorder and early developmental alcohol exposureK99AA028577 · NIAAA · UNIVERSITY OF PENNSYLVANIA · PI EGERVARI, GABOR · 2021 to 2022
$290k
Developing a novel epigenetic regulator as a treatment for opioid use disorderR43DA058603 · NIDA · EPIVARIO, LLC · PI KIM, THOMAS · 2024 to 2024
$275k
Investigating the mechanisms for mutant p53 stability in cancer cellsF31CA247348 · NCI · UNIVERSITY OF PENNSYLVANIA · PI MENDOZA, MARIEL GRACE · 2019 to 2022
$105k
HHS | NIH | National Institute on Deafness and Other Communication Disorders (NIDCD) RO1AA027202NCI NIH HHS F31 CA247348NCI NIH HHS P01 CA196539NIAAA NIH HHS K99 AA027839NIAAA NIH HHS K99 AA028577NIAAA NIH HHS R01 AA027202NIAID NIH HHS R01 AI118891NICHD NIH HHS U54 HD086984NIDA NIH HHS R43 DA058603NIDA NIH HHS R43 DA060726NIGMS NIH HHS T32 GM007229
6 · The paper itself

Abstract

Histone acetylation is a key component in the consolidation of long-term fear memories. Histone acetylation is fueled by acetyl-coenzyme A (acetyl-CoA), and recently, nuclear-localized metabolic enzymes that produce this metabolite have emerged as direct and local regulators of chromatin. In particular, acetyl-CoA synthetase 2 (ACSS2) mediates histone acetylation in the mouse hippocampus. However, whether ACSS2 regulates long-term fear memory remains to be determined. Here, we show that Acss2 knockout is well tolerated in mice, yet the Acss2-null mouse exhibits reduced acquisition of long-term fear memory. Loss of Acss2 leads to reductions in both histone acetylation and expression of critical learning and memory-related genes in the dorsal hippocampus, specifically following fear conditioning. Furthermore, systemic administration of blood-brain barrier-permeable Acss2 inhibitors during the consolidation window reduces fear-memory formation in mice and rats and reduces anxiety in a predator-scent stress paradigm. Our findings suggest that nuclear acetyl-CoA metabolism via ACSS2 plays a critical, previously unappreciated, role in the formation of fear memories.

Indexed as

Acetate-CoA LigaseAcetyl Coenzyme AConditioning, ClassicalFearHistonesMemory ConsolidationAcetylationAnimalsHippocampusMiceMice, KnockoutRatsAcetate-CoA LigaseAcetyl Coenzyme AACSS2 protein, mouseHistonesepigeneticsfear conditioninghistone acetylationlearning and memorymass spectrometry

Identifiers

PMID35921439
PMCPMC9371679
OpenAlexW4289638446

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.